Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy

Fig. 6

Clinical impact curve of the nomogram for predicting pCR in breast cancer received NAC. The red curve shows the predicted improved number at different threshold probabilities and the blue curve represents actual improved patients. The predictive improved number is close to the actual number of positive cases when the threshold probability was greater than 0.2. At this time, the Cost: Benefit ratio was 0.2. It is suggested that the nomogram could accurately predict the probability of pCR after NAC. pCR: Pathological complete response; NAC: Neoadjuvant chemotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us